Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EXOSC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FRMPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01224 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ADAM11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRPPRC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00950 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NID2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM228B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GDE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FNBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on